eli lilly glp 1 drugs The Food and Drug Administration has approved the first oral GLP-1 weight loss drug by Lilly, called Foundayo RO OFFERS ELI LILLY'S FOUNDAYO™,
Description
Drucker D.J
Eli Lilly, which also makes the weight loss drugs Mounjaro and Zepbound, said it plans to complete seven additional phase 3 clinical trials of retatrutide in 2026, compiling data that will be submitted to the U.S
As with all things in biotech, the future is profoundly uncertain, and progress will always have roadblocks
These circulating markers are linked to inflammation and endothelial dysfunction, which can lead to cardiovascular events
A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells
